Discover why Penumbra (PEN) is poised for growth in thrombectomy markets. Explore key studies, upcoming launches, and ...

Penumbra announced the publication of a new study that showed that the use of the company’s computer-assisted vacuum thr ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

Lightning Flash™ is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus Next generation technology combines superior catheter design with the latest ...

Penumbra ($PEN), one of the top devicemaker IPOs last year, unveiled its latest thrombectomy product to the U.S. market. Dubbed the ACE 68 Reperfusion Catheter, the ...

Penumbra, Inc. (NYSE:PEN), a leader in the medical technology sector specializing in thrombectomy devices, has been garnering attention from analysts due to its strong performance and promising ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System’s most ...

MIAMI--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System’s most advanced ...

Penumbra is Friday's IBD Stock Of The Day following a strong third-quarter report and a "landmark" study vs. blood thinners.

Penumbra, Inc. PEN recently received FDA clearance for the RED 62 Reperfusion Catheter. Following this regulatory go-ahead, the company has also initiated commercial availability of the catheter ...